J43.1 Panlobular emphysema

Name of the Condition

• Panlobular emphysema

Summary

Panlobular emphysema is a subtype of emphysema characterized by uniform destruction of the alveoli throughout the lung lobule. This damage impairs gas exchange and reduces lung elasticity, leading to airflow limitation. It is often associated with chronic obstructive pulmonary disease (COPD) and may present with progressive dyspnea and reduced exercise tolerance.

Causes

Panlobular emphysema is primarily caused by long-term exposure to lung irritants, most commonly tobacco smoke. Other contributing factors include occupational exposure to dust or chemical fumes, and rare genetic conditions such as alpha-1 antitrypsin deficiency, which can accelerate alveolar wall destruction.

Risk Factors

• Smoking: The leading risk factor, with prolonged exposure increasing severity.
• Genetic predisposition: Alpha-1 antitrypsin deficiency significantly raises risk.
• Occupational hazards: Prolonged inhalation of dust, fumes, or pollutants.
• Age: More common in older adults due to cumulative lung damage.

Symptoms

• Progressive shortness of breath, especially during exertion.
• Wheezing or labored breathing.
• Chronic cough, often with minimal sputum.
• Reduced exercise capacity and fatigue.
• Barrel-shaped chest in advanced cases.
• Weight loss or decreased appetite in severe stages.

Diagnosis

Diagnosis involves a combination of clinical evaluation, imaging, and pulmonary function tests. Chest X-rays or CT scans may reveal characteristic lung changes, while spirometry assesses airflow limitation. Alpha-1 antitrypsin levels are checked if genetic deficiency is suspected.

Treatment Options

Treatment focuses on symptom management and slowing disease progression. Smoking cessation is critical. Bronchodilators, inhaled corticosteroids, and supplemental oxygen may be prescribed. Pulmonary rehabilitation and vaccinations (e.g., flu, pneumonia) are recommended to reduce exacerbations.

Prognosis and Follow-Up

Prognosis varies based on severity and response to treatment. Regular follow-up with pulmonologists is essential to monitor lung function and adjust therapies. Early intervention can improve quality of life, though the condition is generally progressive.

Complications

• Respiratory failure due to severe airflow limitation.
• Cor pulmonale (right-sided heart failure) from chronic hypoxia.
• Pneumothorax (collapsed lung) from alveolar rupture.
• Increased susceptibility to respiratory infections.

Lifestyle & Prevention

• Avoid smoking and secondhand smoke.
• Minimize exposure to occupational or environmental lung irritants.
• Engage in regular, moderate exercise to maintain lung function.
• Maintain a healthy diet and weight to support overall respiratory health.

When to Seek Professional Help

Seek care if experiencing worsening dyspnea, uncontrolled cough, or signs of infection (e.g., fever, increased sputum). Immediate medical attention is needed for sudden chest pain, severe shortness of breath, or bluish skin discoloration, which may indicate respiratory failure.

Tips for Medical Coders

Document the presence of panlobular emphysema with specificity, noting any associated conditions like alpha-1 antitrypsin deficiency or COPD. Ensure clinical correlation with imaging or pulmonary function test results to support coding accuracy. Avoid coding for unspecified emphysema when this subtype is diagnosed.